Shares of Intrexon Corporation (NYSE:XON) gapped down before the market opened on Monday after Bank of America Corporation lowered their price target on the stock from $25.00 to $21.00. The stock had previously closed at $8.58, but opened at $11.81. Bank of America Corporation currently has a neutral rating on the stock. Intrexon Corporation shares last traded at $12.50, with a volume of 5779955 shares changing hands.
Other analysts have also issued research reports about the company. Zacks Investment Research lowered Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. BidaskClub lowered Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Northland Securities set a $30.00 price target on Intrexon Corporation and gave the company a “buy” rating in a report on Monday, August 7th. JMP Securities reissued an “outperform” rating and set a $42.00 price target on shares of Intrexon Corporation in a report on Thursday, October 5th. Finally, Griffin Securities reissued a “buy” rating and set a $55.00 price target on shares of Intrexon Corporation in a report on Friday, October 6th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $38.50.
In other Intrexon Corporation news, Director Robert B. Shapiro acquired 2,850 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The stock was purchased at an average price of $17.50 per share, with a total value of $49,875.00. Following the completion of the purchase, the director now directly owns 43,157 shares in the company, valued at approximately $755,247.50. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 56.30% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its stake in shares of Intrexon Corporation by 13.8% in the third quarter. Wells Fargo & Company MN now owns 118,462 shares of the biotechnology company’s stock worth $2,252,000 after acquiring an additional 14,333 shares during the period. JPMorgan Chase & Co. boosted its stake in Intrexon Corporation by 7,504.8% during the third quarter. JPMorgan Chase & Co. now owns 59,622 shares of the biotechnology company’s stock valued at $1,122,000 after buying an additional 58,838 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Intrexon Corporation by 493.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,258 shares of the biotechnology company’s stock valued at $271,000 after buying an additional 11,854 shares during the last quarter. Dynamic Technology Lab Private Ltd boosted its stake in Intrexon Corporation by 127.0% during the third quarter. Dynamic Technology Lab Private Ltd now owns 24,640 shares of the biotechnology company’s stock valued at $468,000 after buying an additional 13,783 shares during the last quarter. Finally, Macquarie Group Ltd. boosted its stake in Intrexon Corporation by 25.7% during the third quarter. Macquarie Group Ltd. now owns 35,995 shares of the biotechnology company’s stock valued at $684,000 after buying an additional 7,353 shares during the last quarter. 77.28% of the stock is owned by hedge funds and other institutional investors.
The company has a quick ratio of 1.85, a current ratio of 2.05 and a debt-to-equity ratio of 0.01.
ILLEGAL ACTIVITY WARNING: “Intrexon Corporation (XON) Shares Gap Down Following Analyst Downgrade” was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2017/11/13/intrexon-corporation-xon-shares-gap-down-following-analyst-downgrade.html.
About Intrexon Corporation
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.
Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.